TAYSHA GENE THERAPIES INC (TSHA) Stock Earnings & Estimates
NASDAQ:TSHA - US8776191061 - Common Stock
3.36 USD
+0.1 (+3.07%)
3.29 USD
-0.07 (-2.08%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.5M | 15.451M 518.04% | 8.333M -46.07% | 7.547M -9.43% | 4.167M -44.79% | 15.05M 261.17% | 130.1M 764.45% | 485.31M 273.03% | 974.61M 100.82% | 1.255B 28.77% | 1.517B 20.88% | |
| EBITDA YoY % growth | -124.86M 27.73% | -70.003M 43.93% | -85.376M -21.96% | -97.982M -14.76% | -116.46M -18.86% | 83.057M 171.32% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -126.03M 27.26% | -71.374M 43.37% | -86.621M -21.36% | -107.524M -24.13% | -136.617M -27.06% | -121.834M 10.82% | -66.086M 45.76% | 167.23M 353.05% | 485.83M 190.52% | 639.81M 31.69% | 783.56M 22.47% | |
| Operating Margin | -5,041.20% | -461.94% | -1,039.49% | -1,424.73% | -3,278.55% | -809.53% | -50.80% | 34.46% | 49.85% | 50.98% | 51.65% | |
| EPS YoY % growth | -3.13 32.40% | 0.13 104.15% | -0.36 -376.92% | -0.36 -0.71% | -0.43 -17.90% | -0.42 0.98% | -0.29 31.33% | 0.23 180.70% | 0.99 321.74% | 1.44 45.88% | 1.55 7.42% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 7.83% | -0.10 -37.77% | -0.10 -25.91% | -0.11 -17.58% | -0.11 -20.15% | -0.12 -19.37% |
| Revenue Q2Q % growth | 1.538M -13.98% | 1.674M -17.21% | 1.632M -29.11% | 1.547M -22.10% | 1.207M -21.52% | 1.207M -27.90% |
| EBITDA Q2Q % growth | -31.426M -56.20% | -36.302M -94.26% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.363M -34.68% | -29.925M -50.14% | -31.916M -49.00% | -33.755M -26.17% | -35.922M -26.65% | -37.295M -24.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.09 | -0.08 | -0.01 | -9.04% |
| Q1 2025 Q2Q % growth | -0.08 20.00% | -0.09 | 0.01 | 15.26% |
| Q4 2024 Q2Q % growth | -0.07 -107.61% | -0.08 | 0.01 | 17.32% |
| Q3 2024 Q2Q % growth | -0.10 23.08% | -0.09 | -0.01 | -5.87% |
| Q2 2024 Q2Q % growth | -0.09 76.32% | -0.17 | 0.08 | 46.41% |
| Q1 2024 Q2Q % growth | -0.10 64.29% | -0.11 | 0.01 | 10.38% |
| Q4 2023 Q2Q % growth | 0.92 370.59% | -0.11 | 1.03 | 919.96% |
| Q3 2023 Q2Q % growth | -0.13 79.69% | -0.18 | 0.05 | 26.20% |
| Q2 2023 Q2Q % growth | -0.38 54.76% | -0.32 | -0.06 | -19.75% |
| Q1 2023 Q2Q % growth | -0.28 78.63% | -0.36 | 0.08 | 22.48% |
| Q4 2022 Q2Q % growth | -0.34 74.24% | -0.34 | 0.00 | -1.25% |
| Q3 2022 Q2Q % growth | -0.64 52.59% | -0.83 | 0.19 | 23.17% |
| Q2 2022 Q2Q % growth | -0.84 22.94% | -1.02 | 0.18 | 18.03% |
| Q1 2022 Q2Q % growth | -1.31 -50.57% | -1.09 | -0.22 | -20.35% |
| Q4 2021 Q2Q % growth | -1.32 -26.92% | -1.28 | -0.04 | -3.12% |
| Q3 2021 Q2Q % growth | -1.35 -5.47% | -1.10 | -0.25 | -22.74% |
| Q2 2021 Q2Q % growth | -1.09 | -0.86 | -0.23 | -27.27% |
| Q1 2021 Q2Q % growth | -0.87 | -0.57 | -0.30 | -51.55% |
| Q4 2020 Q2Q % growth | -1.04 | -0.38 | -0.66 | -171.90% |
| Q3 2020 Q2Q % growth | -1.28 | -0.18 | -1.10 | -617.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.986M 78.60% | 1.637M | 349K | 21.32% |
| Q1 2025 Q2Q % growth | 2.302M -32.51% | 1.51M | 792K | 52.45% |
| Q4 2024 Q2Q % growth | 2.022M -43.90% | 2.355M | -333K | -14.14% |
| Q3 2024 Q2Q % growth | 1.788M -62.33% | 1.681M | 107K | 6.37% |
| Q2 2024 Q2Q % growth | 1.112M -53.57% | 2.717M | -1.605M | -59.07% |
| Q1 2024 Q2Q % growth | 3.411M -27.52% | 2.612M | 799K | 30.59% |
| Q4 2023 Q2Q % growth | 3.604M 44.16% | 2.703M | 901K | 33.33% |
| Q3 2023 Q2Q % growth | 4.746M | 2.141M | 2.605M | 121.67% |
| Q2 2023 Q2Q % growth | 2.395M | 1.9M | 495K | 26.05% |
| Q1 2023 Q2Q % growth | 4.706M | 1.02M | 3.686M | 361.37% |
| Q4 2022 Q2Q % growth | 2.5M | 8.345M | -5.845M | -70.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.09% | 7.59% | -7.99% | 3.76% |
| Revenue | -3.57% | -7.01% | 3.57% | 25.55% |